Delivery Order SPE2DB22D2211-SPE2DB25FSDRF
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Azelastine 0.1% (137 mcg) spray in 30 mL containers, with a ceiling value of $3,225.60. This non-competitive delivery order represents a firm fixed-price procurement and is scheduled for completion by August 21, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a...
- The Defense Logistics Agency awarded a $3,541.53 delivery order to AmerisourceBergen Drug Corp for Azelastine 0.1% (137 MCG) spray in 30ML quantities. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 7, 2025, and represents a child order under the vendor's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...
- The Defense Logistics Agency awarded a delivery order valued at $3,991.28 to AmerisourceBergen Drug Corp for Azelastine 0.1% (137 mcg) spray in 30 mL quantities. This non-set-aside, firm fixed-price delivery order was awarded on October 27, 2025, with completion anticipated by October 28, 2025. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This award represents a child contract under a larger indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 15, 2025, for the supply of Azelastine HCL 0.05% drops in 6 mL quantities, with a ceiling value of $6,662.54. This competitively awarded, firm fixed-price delivery order has an ultimate completion date of July 16, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December...
- The Defense Logistics Agency awarded a $1,160.88 firm fixed price delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Azelastine 0.1% (137 mcg) spray in a 30 mL container. The contract, which is not set-aside, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. Performance will be completed by December 12, 2025, with fulfillment occurring...
- The Defense Logistics Agency awarded a delivery order valued at $2,461.70 to AmerisourceBergen Drug Corp for the supply of Azelastine 0.1% (137 micrograms) nasal spray in 30-milliliter units. This competitively awarded, firm fixed-price delivery order was issued on January 7, 2026, with an ultimate completion date of January 8, 2026. The product will be delivered to the place of performance in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's parent...
- This is a $3,376.01 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for the supply of Azelastine 0.1% (137 MCG) spray, a prescription medication, with a completion date of March 6, 2024. This delivery order is placed under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $87 firm fixed price delivery order to Amerisourcebergen Drug Corporation for azelastine hydrochloride nasal spray. As the prime contractor, Amerisourcebergen will supply 4561911878 units of the 0.1% 137 mcg spray to the DLA under a one-day period of performance ending August 24, 2023. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will perform the contract from its facilities in Conshohocken, Pennsylvania. The delivery order was issued...
- The Defense Logistics Agency awarded a $525.78 firm fixed price delivery order to Amerisourcebergen Drug Corporation for azelastine hydrochloride nasal spray. As the prime contractor, Amerisourcebergen will supply 4561926547 units of 0.1% azelastine hydrochloride 137 mcg sprays in 30mL bottles to the DLA from its facility in Conshohocken, Pennsylvania under a period of performance spanning August 24 to August 25, 2023. No subcontractors or set aside designations were indicated. The DLA...
- The Defense Logistics Agency awarded a $290,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for pharmaceutical products. Under this contract, Amerisourcebergen will supply 4562059832 units of Azelastine 0.1% spray, 137 micrograms per 30 milliliter bottle, to the Defense Logistics Agency from its facility in Conshohocken, Pennsylvania. The period of performance is September 6 through September 7, 2023. No subcontractors or set aside designations were identified. This...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSDRFDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Azelastine 0.1% (137 mcg) spray in a 30 ml format, with a ceiling value of $2,352.57. This non-competitive, firm fixed-price delivery order, awarded on August 26, 2025, with an ultimate completion date of August 27, 2025, represents a pharmaceutical supply transaction under DLA's medical procurement operations. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical vendor, supplies a comprehensive range of medications and medical supplies to support military and veteran healthcare systems. The Azelastine product delivery supports DLA's mission to provide pharmaceutical commodities across multiple therapeutic domains to Defense Health Agency and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 8/26/25 |